Aveanna Healthcare Raises 2026 Guidance as Adjusted EBITDA Jumps 26%
Q1 2026 Delivers Surge in Net Income and Earnings Power
Aveanna Healthcare Holdings (NASDAQ: AVAH) unveiled robust first quarter 2026 results, highlighted by a massive increase in net income and strong operational performance across its business lines. Revenue for the quarter climbed 15.9% to $647.92 million, while Adjusted EBITDA surged 25.2% year-over-year to $84.35 million. Net income reached $41.65 million compared to just $5.19 million a year earlier, translating to diluted earnings per share of $0.19, up from $0.03.
Guidance Raised on Momentum and Segment Growth
Management responded to the company’s strong start by revising full-year 2026 targets higher. Aveanna now expects revenue between $2.56 and $2.58 billion (up from $2.54–$2.56 billion) and Adjusted EBITDA between $328 and $332 million, reflecting increased confidence in the business outlook even as the impact of a pending acquisition is excluded.
Segment Highlights: All Engines Firing
The PDS (Private Duty Services) segment drove much of the topline growth, reporting a 16.4% revenue increase and a healthy 10.7% growth in service hours. Home Health & Hospice (HHH) posted a 17.4% revenue increase with strong trends in admissions and episode volumes. Medical Solutions (MS) saw a 7.4% rise in revenue with gross margin percentage improving to 44.7%.
| Segment | Q1 2026 Revenue ($M) | Y/Y Growth (%) | Gross Margin (%) |
|---|---|---|---|
| PDS | 535.65 | 16.40 | 27.90 |
| HHH | 66.61 | 17.40 | 53.70 |
| MS | 45.65 | 7.40 | 44.70 |
Operating Leverage Drives Margin Expansion
Despite a slight dip in gross margin percentage (31.7% vs. 32.8% last year), Aveanna improved its operating income margin to 10.7% from 9.3%, fueled by revenue growth and disciplined corporate cost management (corporate expenses down 8.9% year-over-year).
| Metric | Q1 2026 | Q1 2025 | % Change |
|---|---|---|---|
| Revenue ($M) | 647.92 | 559.22 | 15.90 |
| Net Income ($M) | 41.65 | 5.19 | 702.30 |
| Adj. EBITDA ($M) | 84.35 | 67.35 | 25.20 |
| Operating Margin (%) | 10.70 | 9.30 | 1.40 |
Cash Flow, Liquidity, and Debt: Financial Flexibility Maintained
As of April 4, 2026, cash stood at $189.27 million with additional undrawn credit capacity. Free cash flow was negative ($3.78 million), influenced by investment activity and debt obligations. Total indebtedness was $1.48 billion, diversified across term loans and securitization facilities, but interest rate exposure remains hedged with swaps and caps, helping mitigate risk from rising rates.
Key Takeaways: Execution Remains the Core Story
Aveanna’s strong FY26 guidance hike and segment performance highlight the company’s operational progress. With multiple levers for further growth—pending M&A integration, cost discipline, and expanding patient volumes—management’s upbeat stance appears well-founded. Investors should monitor completion of the Family First Homecare acquisition and normalized cash flow trends, but the current trajectory points to continued top- and bottom-line expansion as the year unfolds.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI